Biology of Blood and Marrow Transplantation
Volume 13, Issue 11 , Pages 1346-1357 , November 2007

Analysis of Hematopoietic Cell Transplants Using Plasma-Depleted Cord Blood Products That Are Not Red Blood Cell Reduced

  • Robert Chow

      Affiliations

    • StemCyte International Cord Blood Center, Arcadia, California
    • StemCyte Taiwan National Cord Blood Center, Linko, Taiwan
    • Corresponding Author InformationCorrespondence and reprint requests: Robert Chow, MD, AM, StemCyte International Cord Blood Center, 1589 West Industrial Park Street, Covina, CA 91722.
  • ,
  • Auayporn Nademanee

      Affiliations

    • City of Hope National Medical Center, Duarte, California
  • ,
  • Joseph Rosenthal

      Affiliations

    • City of Hope National Medical Center, Duarte, California
  • ,
  • Chatchada Karanes

      Affiliations

    • City of Hope National Medical Center, Duarte, California
  • ,
  • Tang-Her Jaing

      Affiliations

    • Chang Gung University and Children’s Hospital, Linko, Taoyuan, Taiwan
  • ,
  • Michael L. Graham

      Affiliations

    • University of Arizona Medical Center, Tucson, Arizona
  • ,
  • Elsa Tsukahara

      Affiliations

    • StemCyte International Cord Blood Center, Arcadia, California
  • ,
  • Brian Wang

      Affiliations

    • StemCyte International Cord Blood Center, Arcadia, California
  • ,
  • David Gjertson

      Affiliations

    • UCLA School of Medicine and UCLA Medical Center, Los Angeles, California
    • UCLA School of Public Health, Los Angeles, California
  • ,
  • Patrick Tan

      Affiliations

    • Mount Elizabeth Hospital, Singapore, Singapore
  • ,
  • Stephen Forman

      Affiliations

    • City of Hope National Medical Center, Duarte, California
  • ,
  • Lawrence D. Petz

      Affiliations

    • StemCyte International Cord Blood Center, Arcadia, California
    • UCLA School of Public Health, Los Angeles, California

Received 8 February 2007 ,Accepted 21 July 2007.

  • Image Result

    Kaplan-Meier estimates of the probability of neutrophil engraftment. For A, all transplants (top panel); B, remission first transplants (second panel from top) and platelet 20 K engraftment for C, all

    Kaplan-Meier estimates of the probability of neutrophil engraftment. For A, all transplants (top panel); B, remission first transplants (second panel from top) and platelet 20 K engraftment for C, all transplants (third panel from top); and D, remission first transplants (bottom panel).

  • Image Result
    All patients—Kaplan-Meier estimates of the probability of A, relapse-free survival of all malignant patients (top panel); B, overall survival of all patients (second panel from top); C, relapse-free s

    All patients—Kaplan-Meier estimates of the probability of A, relapse-free survival of all malignant patients (top panel); B, overall survival of all patients (second panel from top); C, relapse-free survival for remission first transplant patients (third panel from top); and D, overall survival for remission first transplant patients (bottom panel).

PII: S1083-8791(07)00368-0

doi: 10.1016/j.bbmt.2007.07.012

Biology of Blood and Marrow Transplantation
Volume 13, Issue 11 , Pages 1346-1357 , November 2007